ASXL-Related Disorders Natural History Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of California, Los Angeles

About this trial

A registry focused on the natural history, management and treatment of patients with Bohring-Opitz Syndrome (ASXL1), Shashi-Pena Syndrome (ASXL2) and Bainbridge-Ropers Syndrome (ASXL3).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Clinical or molecular diagnosis of an ASXL related disorder

Disqualifiers

No clinical or molecular diagnosis of an ASXL related disorder

Trial population

All patients with molecularly proven or suspected ASXL related disorders

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Natural history, treatment and management strategies of ASXL-related disorders

Use participant surveys including the GRDR CDE standard questions to collect data on disease history and management. Attain primary medical records with goal of publications to enhance treatment, management and understanding of the natural history of ASXL gene disorders.

Time frame
20 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of California, Los Angeles

Lead sponsor

Boston Children's Hospital

Collaborator

Children's Hospital Medical Center, Cincinnati

Collaborator

Duke University

Collaborator